Trial Profile

Antiglucocorticoid augmentation of antiDepressants in Depression: a double-blind randomised placebo-controlled parallel group trial.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Metyrapone (Primary) ; Antidepressants
Indications Major depressive disorder
Focus Therapeutic Use
Acronyms ADD

Most Recent Events

17 Jul 2014 Biomarkers information updated
21 Nov 2013 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network record (Parent trial: UKCRN7801).
18 Jul 2013 Accrual to date is 204% according to United Kingdom Clinical Research Network (Parent trial: UKCRN7801).

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com